Evidence map›Paper›PMID 23370384›Full record

ArticleEMBO reports2013

Efficient RNA virus control in Drosophila requires the RNA methyltransferase Dnmt2.

Zeljko Durdevic, Katharina Hanna, Beth Gold, Tim Pollex, Sara Cherry, Frank Lyko, Matthias Schaefer

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. The life and times of a tRNA.RNA (New York, N.Y.) · 2023
    Review
  7. Pathogens and global health · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. RNA Methylation in Systemic Lupus Erythematosus.Frontiers in cell and developmental biology · 2021
    Review
  18. Cytosine drives evolution of SARS-CoV-2.Environmental microbiology · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Zeljko DurdevicDivision of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Im Neuenheimer Feld 580, Heidelberg 69120, Germany.
Katharina Hanna
Beth Gold
Tim Pollex
Sara Cherry
Frank Lyko
Matthias Schaefer
DKFZ-ZMBH Alliance · DEHeidelberg University · DEUniversity of Pennsylvania · USGerman Cancer Research Center · DE

Funding

The role of autophagy in innate anti-viral immunity in DrosophilaR01AI074951 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2007 to 2017
$4.2M
NIAID NIH HHS R01 AI074951
6 · The paper itself

Abstract

Drosophila use small-interfering RNA mechanisms to limit the amplification of viral genomes. However, it is unclear how small RNA interference components recognize and separate viral from cellular RNA. Dnmt2 enzymes are highly conserved RNA methyltransferases with substrate specificity towards cellular tRNAs. We report here that Dnmt2 is required for efficient innate immune responses in Drosophila. Dnmt2 mutant flies accumulate increasing levels of Drosophila C virus and show activated innate immune responses. Binding of Dnmt2 to DCV RNA suggests that Dnmt2 contributes to virus control directly, possibly by RNA methylation. These observations demonstrate a role for Dnmt2 in antiviral defence.

Indexed as

AnimalsDNA (Cytosine-5-)-MethyltransferasesDrosophilaDrosophila ProteinsImmunity, InnateInsect VirusesMethylationMutationProtein BindingRNA, ViralDNA (Cytosine-5-)-MethyltransferasesDrosophila ProteinsMt2 protein, DrosophilaRNA, Viral

Identifiers

PMID23370384
PMCPMC3589093
OpenAlexW2111647695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.